Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21WAF1/CIP1 and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  T. Jacks,et al.  The retinoblastoma gene family: cousins with overlapping interests. , 1998, Trends in genetics : TIG.

[3]  N. Dean,et al.  Serine/Threonine Protein Phosphatase Type 5 Acts Upstream of p53 to Regulate the Induction of p21WAF1/Cip1 and Mediate Growth Arrest* , 1998, The Journal of Biological Chemistry.

[4]  F. Graham,et al.  Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer. , 1998, Human gene therapy.

[5]  M. Albert,et al.  Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.

[6]  T. Yagi,et al.  Mutated p21WAF1/CIP1/SDI1 lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells , 1998, Oncogene.

[7]  Bernard Ducommun,et al.  p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells , 1998, Oncogene.

[8]  S. Srivastava,et al.  Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells , 1998, Oncogene.

[9]  L. Hengst,et al.  Effects of p21Cip1/Waf1 at Both the G1/S and the G2/M Cell Cycle Transitions: pRb Is a Critical Determinant in Blocking DNA Replication and in Preventing Endoreduplication , 1998, Molecular and Cellular Biology.

[10]  M. Gorospe,et al.  p27Kip1 overexpression causes apoptotic death of mammalian cells , 1997, Oncogene.

[11]  J. Decaprio,et al.  p16INK4A promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells. , 1997, Blood.

[12]  W. Kaelin,et al.  Role of the retinoblastoma protein in the pathogenesis of human cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  L. Cox.  Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1 , 1997, The Journal of pathology.

[14]  T. Liu,et al.  Cytotoxic Effects of Recombinant Adenovirus p53 and Cell Cycle Regulator Genes (p21 sup WAF1/CIP1 and p16 sup CDKN4) in Human Prostate Cancers , 1997 .

[15]  F. Graham,et al.  Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. , 1997, The Journal of general virology.

[16]  M. Roussel,et al.  Features of Macrophage Differentiation Induced by p19INK4d, a Specific Inhibitor of Cyclin D–Dependent Kinases , 1997 .

[17]  M. Strauss,et al.  The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. , 1997, European journal of biochemistry.

[18]  Kenneth Cowan,et al.  A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells , 1997, Oncogene.

[19]  X. Ling,et al.  Combination gene transfer to potentiate tumor regression , 1997, Gene Therapy.

[20]  J. Bartek,et al.  Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death , 1997, Nature Medicine.

[21]  M. Gorospe,et al.  p21Waf1/Cip1 protects against p53-mediated apoptosis of human melanoma cells , 1997, Oncogene.

[22]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[23]  A. Gartel,et al.  p21—Negative Regulator of the Cell Cycle , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[24]  S. Elledge,et al.  A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. , 1996, Trends in cell biology.

[25]  Y. Xiong.  Why are there so many CDK inhibitors? , 1996, Biochimica et biophysica acta.

[26]  R. Lotan,et al.  Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer. , 1996, Cancer research.

[27]  James M. Roberts,et al.  A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.

[28]  K. Manova-Todorova,et al.  Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.

[29]  Nobuyuki Shishido,et al.  Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.

[30]  L. Chin,et al.  Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.

[31]  J. Takahara,et al.  UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. , 1996, Biochemical and biophysical research communications.

[32]  S. Elledge,et al.  Cdk inhibitors in development and cancer. , 1996, Current opinion in genetics & development.

[33]  E. Nabel,et al.  The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo , 1995, Nature Medicine.

[34]  W. Muller,et al.  Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Stephen J. Elledge,et al.  Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.

[36]  J. Roth,et al.  Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector. , 1995, Cancer research.

[37]  Muneesh Tewari,et al.  Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase , 1995, Cell.

[38]  James M. Roberts,et al.  Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.

[39]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[40]  M. Roussel,et al.  Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 , 1995, Molecular and cellular biology.

[41]  A. Kamb,et al.  Cell-cycle regulators and cancer. , 1995, Trends in genetics : TIG.

[42]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[43]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[44]  C. Sherr.  G1 phase progression: Cycling on cue , 1994, Cell.

[45]  F. Graham,et al.  An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Bartek,et al.  DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1 , 1994, The Journal of cell biology.

[47]  G. Wick,et al.  Simultaneous determination of cell surface antigens and apoptosis. , 1994, Trends in genetics : TIG.

[48]  V. Chow,et al.  Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line. , 1993, Cancer letters.

[49]  N. Davidson,et al.  Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. , 1993, Cancer research.

[50]  J. Nevins,et al.  Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[51]  G. Symonds,et al.  Overexpression of the retinoblastoma gene in a familial adrenocortical carcinoma. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[52]  S. Benchimol,et al.  Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells , 1991, Molecular and cellular biology.

[53]  B. Vogelstein,et al.  p53 functions as a cell cycle control protein in osteosarcomas , 1990, Molecular and cellular biology.

[54]  J. E. Celis,et al.  Cell Biology: A Laboratory Handbook , 1997 .

[55]  D. Franklin,et al.  Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6. , 1997, Immunity.

[56]  M. Fey,et al.  Expression and regulation of G1 cell-cycle inhibitors (p16INK4A , p15INK4B, p18 INK4C, p19INK4D ) in human acute myeloid leukemia and normal myeloid cells , 1997, Leukemia.

[57]  X. Graña,et al.  pRB, p107 and p130 as transcriptional regulators: role in cell growth and differentiation. , 1997, Progress in cell cycle research.

[58]  M. Hitt,et al.  [2] Techniques for human adenovirus vector construction and characterization , 1995 .

[59]  W. Lee,et al.  C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.